QUARTERLY REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 |
TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 |
(State or other jurisdiction of | (I.R.S. Employer Identification No.) | |
incorporation or organization) | ||
|
||
(Address of Principal Executive Offices) | (Zip Code) |
Title of each class |
Trading Symbol(s) |
Name of each exchange on which registered | ||
|
|
| ||
☒ |
☐ Accelerated filer | ☐ Non-accelerated filer |
Page |
||||||
1 |
||||||
Item 1. |
||||||
2 |
||||||
3 |
||||||
4 |
||||||
5 |
||||||
6 |
||||||
Item 2. |
18 |
|||||
18 |
||||||
19 |
||||||
21 |
||||||
22 |
||||||
25 |
||||||
Item 3. |
29 |
|||||
Item 4. |
29 |
|||||
Item 1. |
30 |
|||||
Item 1A. |
30 |
|||||
Item 2. |
30 |
|||||
Item 3. |
30 |
|||||
Item 4. |
30 |
|||||
Item 5. |
30 |
|||||
Item 6. |
31 |
|||||
32 |
||||||
Exhibits |
● | COVID-19 |
● | International Operations - worldwide and local economic and market conditions; changes in political conditions; and fluctuations in foreign currency exchange rates and other risks associated with foreign operations, including in emerging markets |
● | Our Business - changes in our markets due to competitive conditions, technological developments, environmental standards, laws and regulations, and customer preferences; fluctuations in demand affecting sales to customers; execution and integration of acquisitions; selling prices; fluctuations in the cost and availability of raw materials and energy; the impact of competitive products and pricing; customer and supplier concentrations or consolidations; the financial condition of distributors; outsourced manufacturers; product and service quality; timely development and market acceptance of new products, including sustainable or sustainably-sourced products; investment in development activities and new production facilities; successful implementation of new manufacturing technologies and installation of manufacturing equipment; our ability to generate sustained productivity improvement; our ability to achieve and sustain targeted cost reductions; and collection of receivables from customers |
● | Income Taxes – fluctuations in tax rates; changes in tax laws and regulations, and uncertainties associated with interpretations of these laws and regulations; retention of tax incentives; outcome of tax audits; and the realization of deferred tax assets |
● | Information Technology - disruptions in information technology systems, including cyber-attacks or other intrusions to network security; successful installation of new or upgraded information technology systems; and data security breaches |
● | Human Capital – recruitment and retention of employees; fluctuations in employee benefit costs; and collective labor arrangements |
● | Our Indebtedness – credit risks; our ability to obtain adequate financing arrangements and maintain access to capital; volatility in financial markets; fluctuations in interest rates; and compliance with our debt covenants |
● | Ownership of Our Stock – potential significant variability of our stock price and amounts of future dividends and share repurchases |
● | Legal and Regulatory Matters - protection and infringement of intellectual property and impact of legal and regulatory proceedings, including with respect to environmental, health and safety, anti-corruption and trade compliance |
● | Other Financial Matters - fluctuations in pension costs and goodwill impairment |
ITEM 1. FINANCIAL STATEMENTS |
(Dollars in millions, except per share amount) |
April 3, 2021 |
January 2, 2021 |
||||||
Assets |
||||||||
Current assets: |
||||||||
Cash and cash equivalents |
$ |
$ |
||||||
Trade accounts receivable, less allowances of $ |
||||||||
Inventories, net |
||||||||
Other current assets |
||||||||
Total current assets |
||||||||
Property, plant and equipment, net |
||||||||
Goodwill |
||||||||
Other intangibles resulting from business acquisitions, net |
||||||||
Deferred tax assets |
||||||||
Other assets |
||||||||
$ |
$ |
|||||||
Liabilities and Shareholders’ Equity |
||||||||
Current liabilities: |
||||||||
Short-term borrowings and current portion of long-term debt and finance leases |
$ |
$ |
||||||
Accounts payable |
||||||||
Accrued payroll and employee benefits |
||||||||
Other current liabilities |
||||||||
Total current liabilities |
||||||||
Long-term debt and finance leases |
||||||||
Long-term retirement benefits and other liabilities |
||||||||
Deferred tax liabilities and income taxes payable |
||||||||
Commitments and contingencies (see Note 12) |
||||||||
Shareholders’ equity: |
||||||||
Common stock, $ April 3, 2021 and January 2, 2021; issued - April 3, 2021 and January 2, 2021; outstanding - |
||||||||
Capital in excess of par value |
||||||||
Retained earnings |
||||||||
Treasury stock at cost, |
( |
) |
( |
) | ||||
Accumulated other comprehensive loss |
( |
) |
( |
) | ||||
Total shareholders’ equity |
||||||||
$ |
$ |
Three Months Ended |
||||||||
(In millions, except per share amounts) |
April 3, 2021 |
March 28, 2020 |
||||||
Net sales |
$ |
$ |
||||||
Cost of products sold |
||||||||
Gross profit |
||||||||
Marketing, general and administrative expense |
||||||||
Other expense (income), net |
||||||||
Interest expense |
||||||||
Other non-operating expense (income), net |
( |
) |
( |
) | ||||
Income before taxes |
||||||||
Provision for (benefit from) income taxes |
||||||||
Equity method investment (losses) gains |
( |
) |
( |
) | ||||
Net income |
$ |
$ |
||||||
|
||||||||
Per share amounts: |
||||||||
Net income per common share |
$ |
$ |
||||||
Net income per common share, assuming dilution |
$ |
$ |
||||||
|
||||||||
Weighted average number of shares outstanding: |
||||||||
Common shares |
||||||||
Common shares, assuming dilution |
Three Months Ended |
||||||||
(In millions) |
April 3, 2021 |
March 28, 2020 |
||||||
Net income |
$ |
$ |
||||||
Other comprehensive income (loss), net of tax: |
||||||||
Foreign currency translation |
( |
) | ||||||
Pension and other postretirement benefits |
||||||||
Cash flow hedges |
( |
) |
||||||
Other comprehensive income (loss), net of tax |
( |
) | ||||||
Total comprehensive income, net of tax |
$ |
$ |
Three Months Ended |
||||||||
(In millions) |
April 3, 2021 |
March 28, 2020 |
||||||
Operating Activities |
||||||||
Net income |
$ |
$ |
||||||
Adjustments to reconcile net income to net cash provided by operating activities: |
||||||||
Depreciation |
||||||||
Amortization |
||||||||
Provision for credit losses and sales returns |
||||||||
Stock-based compensation |
||||||||
Pension plan settlement loss |
— |
|||||||
Deferred taxes and other non-cash taxes |
||||||||
Other non-cash expense and loss (income and gain), net |
||||||||
Changes in assets and liabilities and other adjustments |
( |
) |
( |
) | ||||
Net cash provided by operating activities |
||||||||
|
||||||||
Investing Activities |
||||||||
Purchases of property, plant and equipment |
( |
) |
( |
) | ||||
Purchases of software and other deferred charges |
( |
) |
( |
) | ||||
Proceeds from sales of property, plant and equipment |
— |
|||||||
Proceeds from insurance and sales (purchases) of investments, net |
( |
) |
( |
) | ||||
Proceeds from sale of product line |
— |
|||||||
Payments for acquisitions, net of cash acquired, and investments in businesses |
( |
) |
( |
) | ||||
Net cash used in investing activities |
( |
) |
( |
) | ||||
|
||||||||
Financing Activities |
||||||||
Net increase (decrease) in borrowings (maturities of three months or less) |
( |
) | ||||||
Additional borrowings under revolving credit facility |
— |
|||||||
Additional long-term borrowings |
— |
|||||||
Repayments of long-term debt and finance leases |
( |
) |
( |
) | ||||
Dividends paid |
( |
) |
( |
) | ||||
Share repurchases |
( |
) |
( |
) | ||||
Net (tax withholding) proceeds related to stock-based compensation |
( |
) |
( |
) | ||||
Net cash (used in) provided by financing activities |
( |
) |
||||||
|
||||||||
Effect of foreign currency translation on cash balances |
( |
) |
( |
) | ||||
Increase (decrease) in cash and cash equivalents |
||||||||
Cash and cash equivalents, beginning of year |
||||||||
Cash and cash equivalents, end of period |
$ |
$ |
(In millions) | Label and Graphic Materials |
Retail Branding and Information Solutions |
Industrial and Healthcare Materials |
Total |
||||||||||||
Goodwill as of January 2, 2021 |
$ | $ | $ | $ | |
|||||||||||
Acquisitions (1) |
— | |||||||||||||||
Acquisition adjustment (2) |
— | — | ||||||||||||||
Translation adjustments |
( |
) | ( |
) | ( |
) | ( |
) | ||||||||
Goodwill as of April 3, 2021 |
$ | $ | $ | $ |
(1) |
Goodwill acquired related to the acquisitions of JDC and ZippyYum. We expect the recognized goodwill related to the JDC acquisition not to be deductible for income tax purposes and the recognized goodwill related to the ZippyYum acquisition to be deductible for income tax purposes. |
(2) |
Measurement period adjustment related to the finalization of the purchase price allocation for the acquisition of ACPO, Ltd. completed in December 2020. |
(In millions) | Accrual at January 2, 2021 |
Charges, Net of Reversals |
Cash Payments |
Non-cash Impairment |
Foreign Currency Translation |
Accrual at April 3, 2021 |
||||||||||||||||||
2019/2020 Actions |
||||||||||||||||||||||||
Severance and related costs |
$ |
$ | $ | ( |
) | $ |
— | $ |
( |
) | $ |
|||||||||||||
Asset impairment |
— | — | ( |
) | — | — | ||||||||||||||||||
Total |
$ | $ |
$ | ( |
) | $ | ( |
) | $ |
( |
) | $ |
Three Months Ended |
||||||||
(In millions) |
April 3, 2021 |
March 28, 2020 |
||||||
Restructuring charges, net of reversals, by reportable segment and Corporate |
||||||||
Label and Graphic Materials |
$ |
$ |
||||||
Retail Branding and Information Solutions |
||||||||
Industrial and Healthcare Materials |
||||||||
Corporate |
||||||||
Total |
$ |
$ |
Three Months Ended |
||||||||
(Dollars in millions) | April 3, 2021 |
March 28, 2020 |
||||||
Income before taxes |
$ | $ | ||||||
Provision for (benefit from) income taxes |
||||||||
Effective tax rate |
% | % |
Three Months Ended |
||||||||
(In millions, except per share amounts) |
April 3, 2021 |
March 28, 2020 |
||||||
(A) Net income |
$ |
$ |
||||||
(B) Weighted average number of common shares outstanding |
||||||||
Dilutive shares (additional common shares issuable under stock-based awards) |
||||||||
(C) Weighted average number of common shares outstanding, assuming dilution |
||||||||
Net income per common share: (A) ÷ (B) |
$ |
$ |
||||||
Net income per common share, assuming dilution: (A) ÷ (C) |
$ |
$ |
Three Months Ended |
||||||||
(In millions) |
April 3, 2021 |
March 28, 2020 |
||||||
Common stock issued, $1 par value per share |
$ |
$ |
||||||
Capital in excess of par value |
||||||||
Beginning balance |
$ |
$ |
||||||
Issuance of shares under stock-based compensation plans (1) |
( |
) |
( |
) | ||||
Ending balance |
$ |
$ |
||||||
Retained earnings |
||||||||
Beginning balance |
$ |
$ |
||||||
Net income |
||||||||
Issuance of shares under stock-based compensation plans (1) |
( |
) |
( |
) | ||||
Contribution of shares to 401(k) Plan (1) |
||||||||
Dividends |
( |
) |
( |
) | ||||
Ending balance |
$ |
$ |
||||||
Treasury stock at cost |
||||||||
Beginning balance |
$ |
( |
) |
$ |
( |
) | ||
Repurchase of shares for treasury |
( |
) |
( |
) | ||||
Issuance of shares under stock-based compensation plans (1) |
||||||||
Contribution of shares to 401(k) Plan (1) |
||||||||
Ending balance |
$ |
( |
) |
$ |
( |
) | ||
Accumulated other comprehensive loss |
||||||||
Beginning balance |
$ |
( |
) |
$ |
( |
) | ||
Other comprehensive income (loss), net of tax |
( |
) | ||||||
Ending balance |
$ |
( |
) |
$ |
( |
) |
(1) |
We fund a portion of our employee-related expenses using shares of our common stock held in treasury. We reduce capital in excess of par value based on the grant date fair value of the awards vested and record net gains or losses associated with our use of treasury shares to retained earnings. |
Three Months Ended |
||||||||
April 3, 2021 |
March 28, 2020 |
|||||||
Dividends per common share |
$ | $ |
(In millions) | Foreign Currency Translation |
Pension and Other Postretirement Benefits |
Cash Flow Hedges |
Total |
||||||||||||
Balance as of January 2, 2021 |
$ | ( |
) | $ | ( |
) | $ | ( |
) | $ | ( |
) | ||||
Other comprehensive income (loss) before reclassifications, net of tax |
— | ( |
) | |||||||||||||
Reclassifications to net income, net of tax |
— | ( |
) | |||||||||||||
Other comprehensive income (loss), net of tax |
( |
) | ||||||||||||||
Balance as of April 3, 2021 |
$ | ( |
) | $ | ( |
) | $ | ( |
) | $ | ( |
) |
(In millions) | Foreign Currency Translation |
Pension and Other Postretirement Benefits |
Cash Flow Hedges |
Total |
||||||||||||
Balance as of December 28, 2019 |
$ | ( |
) | $ | ( |
) | $ | ( |
) | $ | ( |
) | ||||
Other comprehensive income (loss) before reclassifications, net of tax |
( |
) | — | ( |
) | |||||||||||
Reclassifications to net income, net of tax |
— | ( |
) | |||||||||||||
Other comprehensive income (loss), net of tax |
( |
) | ( |
) | ||||||||||||
Balance as of March 28, 2020 |
$ | ( |
) | $ | ( |
) | $ | $ | ( |
) |
Fair Value Measurements Using |
||||||||||||||||
(In millions) | Total |
Quoted Prices in Active Markets (Level |
Significant Other Observable Inputs (Level 2) |
Significant Other Unobservable Inputs (Level 3) |
||||||||||||
Assets |
||||||||||||||||
Investments |
$ | $ | $ | $ | — | |||||||||||
Derivative assets |
— | — | ||||||||||||||
Bank drafts |
— | — | ||||||||||||||
Liabilities |
||||||||||||||||
Cross-currency swap |
$ | $ | — | $ | $ | — | ||||||||||
Derivative liabilities |
— | |||||||||||||||
Contingent consideration liabilities |
— | — |
Fair Value Measurements Using |
||||||||||||||||
(In millions) | Total |
Quoted Prices in Active Markets (Level 1) |
Significant Other Observable Inputs (Level 2) |
Significant Other Unobservable Inputs (Level 3) |
||||||||||||
Assets |
||||||||||||||||
Investments |
$ | $ | $ | $ | — | |||||||||||
Derivative assets |
— | |||||||||||||||
Bank drafts |
— | — | ||||||||||||||
Liabilities |
||||||||||||||||
Cross-currency swap |
$ | $ | — | $ | $ | — | ||||||||||
Derivative liabilities |
— |
(In millions) | ||||
Balance at January 2, 2021 |
$ | |||
Charges, net of reversals |
||||
Payments |
( |
) | ||
Balance at April 3, 2021 |
$ | |
Three Months Ended |
||||||||
(In millions) |
April 3, 2021 |
March 28, 2020 |
||||||
Net sales to unaffiliated customers |
||||||||
Label and Graphic Materials: |
||||||||
U.S. (1) |
$ |
$ |
||||||
Europe, Middle East and North Africa (1) |
||||||||
Asia (1) |
||||||||
Latin America |
||||||||
Other international |
||||||||
Total Label and Graphic Materials (1) |
||||||||
Retail Branding and Information Solutions: |
||||||||
Apparel (1) |
||||||||
Printer Solutions |
||||||||
Total Retail Branding and Information Solutions (1) |
||||||||
Industrial and Healthcare Materials |
||||||||
Net sales to unaffiliated customers |
$ |
$ |
(1) |
In the first quarter of 2020, an insignificant portion of the net sales and associated operating loss related to the acquisition of Smartrac’s Transponder (RFID Inlay) division (“Smartrac”) was reported in our LGM reportable segment’s results, reflecting sales through that segment’s channels. To better align the reporting with our current organizational structure, the results associated with the acquisition were reclassified and are now included solely in the results for our RBIS reportable segment in both periods presented above. |
Three Months Ended |
||||||||
(In millions) |
April 3, 2021 |
March 28, 2020 |
||||||
Intersegment sales |
||||||||
Label and Graphic Materials |
$ |
$ |
||||||
Retail Branding and Information Solutions |
||||||||
Industrial and Healthcare Materials |
||||||||
Intersegment sales |
$ |
$ |
||||||
Income before taxes |
||||||||
Label and Graphic Materials (1) |
$ |
$ |
||||||
Retail Branding and Information Solutions (1) |
||||||||
Industrial and Healthcare Materials |
||||||||
Corporate expense |
( |
) |
( |
) | ||||
Interest expense |
( |
) |
( |
) | ||||
Other non-operating expense (income), net |
||||||||
Income before taxes |
$ |
$ |
||||||
Other expense (income), net, by reportable segment and Corporate |
||||||||
Label and Graphic Materials (1) |
$ |
( |
) |
$ |
||||
Retail Branding and Information Solutions (1) |
||||||||
Industrial and Healthcare Materials |
||||||||
Corporate |
||||||||
Other expense (income), net |
$ |
$ |
||||||
Other expense (income), net, by type |
||||||||
Restructuring charges: |
||||||||
Severance and related costs |
$ |
$ |
||||||
Asset impairment charges and lease cancellation costs |
||||||||
Other items: |
||||||||
Outcome of legal proceedings |
||||||||
Transaction and related costs |
||||||||
Gain on sale of product line |
( |
) |
||||||
Other expense (income), net |
$ |
$ |
(1) |
In the first quarter of 2020, an insignificant portion of the net sales and associated operating loss related to the acquisition of Smartrac was reported in our LGM reportable segment’s results, reflecting sales through that segment’s channels. To better align the reporting with our current organizational structure, the results associated with the acquisition were reclassified and are now included solely in the results for our RBIS reportable segment in both periods presented above. |
(In millions) |
April 3, 2021 |
January 2, 2021 |
||||||
Raw materials |
$ |
$ |
||||||
Work-in-progress |
||||||||
Finished goods |
||||||||
Inventories, net |
$ |
$ |
(In millions) |
April 3, 2021 |
January 2, 2021 |
||||||
Property, plant and equipment |
$ |
$ |
||||||
Accumulated depreciation |
( |
) |
( |
) | ||||
Property, plant and equipment, net |
$ |
$ |
Three Months Ended |
||||||||
(In millions) |
April 3, 2021 |
March 28, 2020 |
||||||
Balance at January 2, 2021 |
$ |
|
$ |
|
| |||
Provision for (reversal of) credit losses (1) |
( |
) |
|
|
| |||
Amounts written off |
( |
) |
|
|
( |
) | ||
Other, including foreign currency translation |
( |
) |
|
|
( |
) | ||
Balance at April 3, 2021 |
$ |
|
$ |
|
(1) |
For the three months ended March 28, 2020, our provision for credit losses reflected impacts on customers as a result of COVID-19. |
● | Sales change ex. currency |
● | Organic sales change |
● | Free cash flow |
● | Operational working capital as a percentage of annualized current quarter net sales held-for-sale day-to-day |
Three Months Ended April 3, 2021 |
||||
Reported sales change |
19 | % | ||
Foreign currency translation |
(4 | ) | ||
Extra week impact |
(4 | ) | ||
Sales change ex. currency (1) |
11 | |||
Acquisitions and product line exit |
(2 | ) | ||
Organic sales change (1) |
9 | % |
(1) |
Totals may not sum due to rounding |
● | Higher volume/mix |
● | Lower allowances for credit losses |
● | Benefits from productivity initiatives, including savings from restructuring actions, net of transition costs |
● | Higher employee-related costs |
● | Net impact of pricing and raw material input costs |
Three Months Ended |
||||||||
(In millions) |
April 3, 2021 |
March 28, 2020 |
||||||
Net cash provided by operating activities |
$ |
209.3 |
$ |
4.4 |
||||
Purchases of property, plant and equipment |
(25.2 |
) |
(33.2 |
) | ||||
Purchases of software and other deferred charges |
(2.3 |
) |
(6.2 |
) | ||||
Proceeds from sales of property, plant and equipment |
.7 |
— |
||||||
Proceeds from insurance and sales (purchases) of investments, net |
(.5 |
) |
(.3 |
) | ||||
Free cash flow |
$ |
182.0 |
$ |
(35.3 |
) |
● | We expect net sales to increase by approximately 10% to 12%, including an increase of 2% from the effect of foreign currency translation and a decrease of 1% related to the calendar shift resulting from the extra week in 2020. |
● | Based on recent exchange rates, we expect foreign currency translation to increase our operating income by approximately $25 million. |
● | We expect incremental savings from restructuring actions, net of transition costs, of approximately $70 million. |
● | We expect our full year effective tax rate to be in the mid-twenty percent range. |
Three Months Ended |
||||||||
(In millions, except percentages) | April 3, 2021 |
March 28, 2020 |
||||||
Net sales |
$ | 2,051.3 | $ | 1,723.0 | ||||
Cost of products sold |
1,454.3 | 1,237.9 | ||||||
Gross profit |
597.0 | 485.1 | ||||||
Marketing, general and administrative expense |
312.3 | 281.0 | ||||||
Other expense (income), net |
.9 | 4.9 | ||||||
Interest expense |
16.2 | 18.8 | ||||||
Other non-operating expense (income), net |
(1.3 | ) | (.5 | ) | ||||
Income before taxes |
$ | 268.9 | $ | 180.9 | ||||
|
||||||||
Gross profit margin |
29.1 | % | 28.2 | % |
Three Months Ended |
||||||||
(In millions) | April 3, 2021 |
March 28, 2020 |
||||||
Other expense (income), net, by type |
||||||||
Restructuring charges: |
||||||||
Severance and related costs |
$ | 2.4 | $ | 2.4 | ||||
Asset impairment charges and lease cancellation costs |
.5 | — | ||||||
Other items: |
||||||||
Outcome of legal proceedings |
2.1 | — | ||||||
Transaction and related costs |
.7 | 2.5 | ||||||
Gain on sale of product line |
(4.8 | ) | — | |||||
Other expense (income), net |
$ | .9 | $ | 4.9 |
Three Months Ended |
||||||||
(In millions, except per share amounts and percentages) | April 3, 2021 |
March 28, 2020 |
||||||
Income before taxes |
$ | 268.9 | $ | 180.9 | ||||
Provision for (benefit from) income taxes |
58.1 | 46.3 | ||||||
Equity method investment (losses) gains |
(1.3 | ) | (.4 | ) | ||||
Net income |
$ | 209.5 | $ | 134.2 | ||||
Per share amounts: |
||||||||
Net income per common share |
$ | 2.52 | $ | 1.61 | ||||
Net income per common share, assuming dilution |
2.50 | 1.60 | ||||||
|
||||||||
Effective tax rate |
21.6 | % | 25.6 | % |
Three Months Ended |
||||||||
(In millions) | April 3, 2021 |
March 28, 2020 |
||||||
Net sales including intersegment sales |
$ | 1,398.6 | $ | 1,195.9 | ||||
Less intersegment sales |
(21.6 | ) | (22.4 | ) | ||||
Net sales |
$ | 1,377.0 | $ | 1,173.5 | ||||
Operating income (1) |
226.2 | 172.5 | ||||||
|
||||||||
(1) Included charges associated with restructuring actions and transaction and related costs in both years, and outcome of legal proceedings and gain on sale of product line in 2021 |
$ | (1.9 | ) | $ | 1.1 |
Three Months Ended April 3, 2021 |
||||
Reported sales change |
17 | % | ||
Foreign currency translation |
(5 | ) | ||
Extra week impact |
(4 | ) | ||
Sales change ex. currency (1) |
8 | |||
Acquisitions and product line exit |
(1 | ) | ||
Organic sales change (1) |
8 | % |
(1) |
Totals may not sum due to rounding |
Three Months Ended |
||||||||
(In millions) | April 3, 2021 |
March 28, 2020 |
||||||
Net sales including intersegment sales |
$ | 491.0 | $ | 408.4 | ||||
Less intersegment sales |
(8.3 | ) | (6.5 | ) | ||||
Net sales |
$ | 482.7 | $ | 401.9 | ||||
Operating income (1) |
60.0 | 30.9 | ||||||
|
||||||||
(1) Included charges associated with restructuring actions and transaction and related costs in both years, and loss on sale of asset in 2021 |
$ | 2.1 | $ | 3.3 |
Three Months Ended April 3, 2021 |
||||
Reported sales change |
20 | % | ||
Foreign currency translation |
(2 | ) | ||
Extra week impact |
(3 | ) | ||
Sales change ex. currency (1) |
15 | |||
Acquisitions |
(6 | ) | ||
Organic sales change (1) |
9 | % |
(1) |
Totals may not sum due to rounding |
Three Months Ended |
||||||||
(In millions) |
April 3, 2021 |
March 28, 2020 |
||||||
Net sales including intersegment sales |
$ |
193.7 |
$ |
149.2 |
||||
Less intersegment sales |
(2.1 |
) |
(1.6 |
) | ||||
Net sales |
$ |
191.6 |
$ |
147.6 |
||||
Operating income (1) |
23.5 |
14.9 |
||||||
|
||||||||
(1) Included transaction and related costs and gain on sale of assets in 2021 and charges associated with restructuring actions in 2020 |
$ |
.1 |
$ |
.5 |
Three Months Ended April 3, 2021 |
||||
Reported sales change |
30 | % | ||
Foreign currency translation |
(7 | ) | ||
Extra week impact |
(5 | ) | ||
Sales change ex. currency (1) |
19 | |||
Acquisitions |
(3 | ) | ||
Organic sales change (1) |
16 | % |
(1) |
Totals may not sum due to rounding |
Three Months Ended |
||||||||
(In millions) |
April 3, 2021 |
March 28, 2020 |
||||||
Net income |
$ |
209.5 |
$ |
134.2 |
||||
Depreciation |
40.0 |
36.8 |
||||||
Amortization |
14.4 |
10.7 |
||||||
Provision for credit losses and sales returns |
8.9 |
31.2 |
||||||
Stock-based compensation |
9.9 |
6.3 |
||||||
Pension plan settlement loss |
.4 |
— |
||||||
Deferred taxes and other non-cash taxes |
1.5 |
6.4 |
||||||
Other non-cash expense and loss (income and gain), net |
2.7 |
4.4 |
||||||
Changes in assets and liabilities and other adjustments |
(78.0 |
) |
(225.6 |
) | ||||
Net cash provided by operating activities |
$ |
209.3 |
$ |
4.4 |
Three Months Ended |
||||||||
(In millions) |
April 3, 2021 |
March 28, 2020 |
||||||
Purchases of property, plant and equipment |
$ |
(25.2 |
) |
$ |
(33.2 |
) | ||
Purchases of software and other deferred charges |
(2.3 |
) |
(6.2 |
) | ||||
Proceeds from sales of property, plant and equipment |
.7 |
— |
||||||
Proceeds from insurance and sales (purchases) of investments, net |
(.5 |
) |
(.3 |
) | ||||
Proceeds from sale of product line |
6.7 |
— |
||||||
Payments for acquisitions, net of cash acquired, and investments in businesses |
(30.6 |
) |
(245.9 |
) | ||||
Net cash used in investing activities |
$ |
(51.2 |
) |
$ |
(285.6 |
) |
Three Months Ended |
||||||||
(In millions) |
April 3, 2021 |
March 28, 2020 |
||||||
Net increase (decrease) in borrowings (maturities of three months or less) |
$ |
53.8 |
$ |
(106.0 |
) | |||
Additional borrowings under revolving credit facility |
— |
500.0 |
||||||
Additional long-term borrowings |
— |
494.4 |
||||||
Repayments of long-term debt and finance leases |
(1.5 |
) |
(1.1 |
) | ||||
Dividends paid |
(51.6 |
) |
(48.4 |
) | ||||
Share repurchases |
(55.6 |
) |
(45.2 |
) | ||||
Net (tax withholding) proceeds related to stock-based compensation |
(25.3 |
) |
(20.0 |
) | ||||
Net cash (used in) provided by financing activities |
$ |
(80.2 |
) |
$ |
773.7 |
(In millions) | Three Months Ended April 3, 2021 |
|||
Change in net sales |
$ | 66 |
(In millions, except percentages) |
April 3, 2021 |
March 28, 2020 |
||||||
(A) Working capital |
$ |
573.9 |
$ |
353.5 |
||||
Reconciling items: |
||||||||
Cash and cash equivalents |
(328.0 |
) |
(742.0 |
) | ||||
Other current assets |
(216.3 |
) |
(225.8 |
) | ||||
Short-term borrowings and current portion of long-term debt and finance leases |
116.9 |
832.3 |
||||||
Accrued payroll and employee benefits and other current liabilities |
763.6 |
697.0 |
||||||
(B) Operational working capital |
$ |
910.1 |
$ |
915.0 |
||||
(C) First-quarter net sales, annualized |
$ |
8,205.2 |
$ |
6,892.0 |
||||
Operational working capital, as a percentage of annualized current-quarter net sales: (B) ÷ (C) |
11.1 |
% |
13.3 |
% |
(a) | Not Applicable |
(b) | Not Applicable |
(c) | Repurchases of Equity Securities by Issuer |
Period (1) |
Total number of shares purchased (2) |
Average price paid per share |
Total number of shares purchased as part of publicly announced plans (2)(3) |
Approximate dollar value of shares that may yet be purchased under the plans (4) |
||||||||||||
January 3, 2021 - January 30, 2021 |
115.0 | $ | 157.94 | 115.0 | $ | 522.2 | ||||||||||
January 31, 2021 - February 27, 2021 |
40.3 | 158.94 | 40.3 | 515.8 | ||||||||||||
January 28, 2021 - April 3, 2021 |
171.9 | 180.23 | 171.9 | 484.8 | ||||||||||||
Total |
327.2 | $ | 169.78 | 327.2 | $ | 484.8 |
(1) |
The periods shown are our fiscal periods during the thirteen-week quarter ended April 3, 2021. |
(2) |
Shares in thousands. |
(3) |
In April 2019, our Board authorized the repurchase of shares of our common stock with a fair market value of up to $650 million, exclusive of any fees, commissions or other expenses related to such purchases. This Board authorization will remain in effect until shares in the amount authorized thereunder have been repurchased. |
(4) |
Dollars in millions. |
* | Filed herewith. |
** | Furnished herewith. |
*** | Furnished herewith. Pursuant to Rule 406T of Regulation S-T, the Interactive Data Files on Exhibit 101 hereto are deemed not filed or part of a registration statement or prospectus for purposes of Sections 11 or 12 of the Securities Act, are deemed not filed for purposes of Section 18 of the Exchange Act and otherwise are not subject to liability under those sections. |
AVERY DENNISON CORPORATION |
(Registrant) |
/s/ Gregory S. Lovins |
Gregory S. Lovins |
Senior Vice President and Chief Financial Officer |
(Principal Financial Officer) |
/s/ Lori J. Bondar |
Lori J. Bondar |
Vice President, Controller, Treasurer, and Chief Accounting Officer |
(Principal Accounting Officer) |
May 4, 2021 |